Charles River Laboratories International Inc

Rating: 0/5 - Write A Review
251 Ballardvale Street
Wilmington, MA 01887

About Charles River Laboratories International Inc

Charles River supports customers’ efforts to discover new therapies for improved human health, beginning with the earliest use of research models in discovery and continuing across the development pipeline through proof of concept. From our commitment to ensuring continuous global availability of standardized animal models, to the expert design and conduct of safety and efficacy studies, we are focused on providing customers with exactly what they need to deliver new therapeutics to patients who need them, as fast as possible and with uncompromising quality. With multiple locations around the world and capabilities spanning each phase of the drug development continuum, Charles River is the ideal partner for moving your product from animal to man in a rational, cost-effective, and timely manner.

Competitors of Charles River Laboratories International Inc

NAMSA

NAMSA is medical research organization providing expert regulatory, laboratory, clinical, and compliance services to medical device and healthcare product manufacturers. At every stage of the product development process, we provide strategic guidance and tactical support to help clients... Read More

DPT Laboratories Ltd

DPT Laboratories Ltd is a leading contract development and manufacturing organization (CDMO) specializing in semi-solid and liquid pharmaceutical dosage forms. Our capabilities span pre-formulation to clinical trial supplies, with a particular focus on semi-solids and liquids such as aerosols,... Read More

  • write a review

West Pharmaceutical Services Inc

Pharmaceutical, biopharmaceutical and medical device companies rely on West for standard-setting systems and device components for parenterally administered medicines. West’s proprietary materials science, formulation research, and manufacturing innovation advance the quality, therapeutic... Read More

9/17/24- Pharm Mfg. - MR
Pharma_3:1_8.14.19
9/17/24- Pharm Mfg. - MR
Pharma_3:1_8.14.19